Harbor Health Care ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Harbor Health Care ETF MEDI
Morningstar’s Analysis MEDI
Will MEDI outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MEDI management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MEDI’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 65.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 21.23 | 8M | Healthcare |
Ascendis Pharma AS | 15.54 | 6M | Healthcare |
Legend Biotech Corp ADR | 5.62 | 2M | Healthcare |
Gilead Sciences Inc | 4.16 | 2M | Healthcare |
Rhythm Pharmaceuticals Inc | 3.67 | 1M | Healthcare |
AbbVie Inc | 3.61 | 1M | Healthcare |
Intuitive Surgical Inc | 3.42 | 1M | Healthcare |
Abivax SA ADR | 3.07 | 1M | Healthcare |
Insmed Inc | 2.85 | 1M | Healthcare |
Boston Scientific Corp | 2.75 | 1M | Healthcare |
United States